<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Carbonic anhydrase IX":1,
"Cholangiocarcinoma":1,
"Clear cell carcinoma of the ovary and uterus":1,
"Hepatocellular carcinoma":2,
"Normal kidney":1,
"Renal cell carcinoma":1,
"Breast cancer":5,
"Clinical features":1,
"Pathological features":1,
"Systemic therapy":2,
"Type 2 diabetes":1,
"FNAB":1,
"Nodule depth":1,
"Pain":2,
"Thyroid nodule":6,
"VAS score":1,
"distant metastasis":1,
"follicular variant of papillary thyroid carcinoma":1,
"risk factor":1,
"FNAC":1,
"Frozen sections":1,
"Thyroid cancer":22,
"Thyroid nodules":4,
"Thyroid surgery":2,
"IMRT":1,
"Intracranial extension":1,
"Nasopharyngeal carcinoma":3,
"Survival":2,
"Toxicity":1,
"Curcumin":1,
"PI3K/Akt and ERK pathways":1,
"antitumour":1,
"sorafenib":2,
"Epidemiology":5,
"Heavy metals":1,
"Trace elements":1,
"Volcanic area":1,
"Endoscopy":1,
"Papillary thyroid carcinoma":5,
"Thyroidectomy":3,
"Case-matched study":1,
"Disease-free survival":1,
"Long-term oncologic outcome":1,
"Papillary thyroid cancer":5,
"Robotic thyroidectomy":2,
"minimally invasive surgery":1,
"remote access":1,
"retroauricular":1,
"Acoustic radiation force impulse":1,
"Conventional ultrasound":2,
"Virtual touch tissue imaging":1,
"Follicular carcinoma":3,
"Micropapillary carcinoma":1,
"Primary squamous cell carcinoma":1,
"Thyroid":18,
"Elastography":2,
"Precompression":1,
"Shear wave imaging":1,
"Ultrasound":3,
"FMTC":1,
"MEN2A":1,
"MEN2B":1,
"RET":1,
"Thyroid carcinoma":3,
"diversity":1,
"medullary":1,
"mutation":1,
"population":1,
"proto-oncogene":1,
"Cabozantinib":1,
"Calcitonin":3,
"Carcinoembryonic antigen":1,
"Medullary thyroid carcinoma":2,
"Review":2,
"Vandetanib":2,
"ACTH = adrenocorticotrophic hormone":1,
"ENT = ear, nose, and throat":1,
"FSH = follicle-stimulating hormone":1,
"GH = growth hormone":1,
"IGF-1 = insulin-like growth factor–1":1,
"LH = luteinizing hormone":1,
"TSH = thyroid-stimulating hormone":1,
"binostril":1,
"mononostril":1,
"neuroendoscopy":1,
"pituitary surgery":1,
"transsphenoidal":1,
"Contrast-enhanced ultrasound":1,
"Sonographic features":1,
"Cancer":6,
"Fetal cells":1,
"Microchimerism":1,
"Women":1,
"Bevacizumab":1,
"Chemotherapy":1,
"Colorectal cancer":1,
"Irinotecan":1,
"S-1":1,
"Cytology":6,
"Fine-needle aspiration":1,
"Report":1,
"biomedical engineering":1,
"endocrine surgery":1,
"evidence-based medicine/surgery":1,
"surgical education":1,
"apocrine":1,
"breast":1,
"napsin A":1,
"Carcinoma":2,
"Follicular":4,
"Minimally invasive":1,
"Prognosis":8,
"Follow-up":1,
"lobectomy":1,
"papillary thyroid microcarcinoma":1,
"ultrasonography":3,
"Dehydroepiandrosterone sulfate":1,
"growth hormone":1,
"obesity":1,
"prolactin":1,
"prolactinoma":1,
"Estradiol":1,
"Glycosylated hemoglobin":1,
"Insulin resistance index":1,
"MiR-124a":1,
"MiR-30d":1,
"Type 2 diabetes mellitus":1,
"Inflammatory bowel disease":1,
"cancer risk":2,
"phenotype":1,
"Biomarker":1,
"Metabolism pathway":1,
"Papillary thyroid cancer (PTC)":1,
"Targeted metabolomics":1,
"Untargeted metabolomics":1,
"Bethesda categories":1,
"Thyroid malignancy":1,
"Thyrotropin":1,
"Diagnosis":4,
"Meta-analysis":3,
"Radiofrequency ablation":1,
"cancer genetics":1,
"case-control study":1,
"fine-mapping study":1,
"immunohistochemistry":2,
"macroadenoma":1,
"metastasis":3,
"pituitary":1,
"sella":1,
"CO2 laser":1,
"Transoral surgery":1,
"hypopharyngeal cancer":1,
"laryngeal preservation":1,
"surgical histoanatomy":1,
"ERK":1,
"cell cycle":1,
"cyclin E":1,
"metastasis suppressor":1,
"p27kip1":1,
"pancreatic ductal adenocarcinoma":1,
"shRNA":1,
"131I":1,
"Biological dosimetry":1,
"Chromosome aberration":1,
"Differentiated thyroid carcinoma":3,
"Recombinant human thyroid-stimulating hormone":1,
"Thyroid hormone withdrawal":1,
"follicular thyroid cancer":1,
"papillary":3,
"well differentiated":1,
"cartilage invasion":1,
"laryngeal cancer":1,
"larynx preservation":1,
"total laryngectomy":1,
"Fine-needle aspiration (FNA) cytology":1,
"Immunohistochemical (IHC) marker":1,
"Non–small cell lung carcinoma (NSCLC)":1,
"P40":1,
"TTF-1 and Napsin A":1,
"Encapsulated":1,
"Follicular variant papillary carcinoma":2,
"NIFTP":1,
"Microwave":1,
"radiofrequency":1,
"thermal ablation":1,
"CK5/6":1,
"Cytokeratin":1,
"Lymphoepithelial complex":1,
"P63":1,
"Squamous cell metaplasia":1,
"Thyroiditis":1,
"epistemology":1,
"philosophy of medicine":1,
"Carcinogenesis":1,
"LOC100507661":1,
"Long noncoding RNA":1,
"Cancer-specific mortality":1,
"Radioactive iodide":1,
"Thyroglobulin":1,
"Total thyroidectomy":2,
"Hashimoto thyroiditis":1,
"Tg":1,
"TgAb":1,
"CT":1,
"fatty lesion":1,
"lipoma":1,
"sonography":2,
"DUOX":1,
"NOX":1,
"Oxidative stress":1,
"TERT":1,
"Follicular adenoma":1,
"Follicular-patterned lesion":1,
"Nodular Hyperplasia":2,
"BRAF":2,
"EMT":1,
"Fibronectin":1,
"Apoptosis":2,
"ERα/Sp1":1,
"ERβ":1,
"Hsp27":1,
"Proliferation":2,
"Immunoassay":1,
"CCK2R-targeting of tumours":1,
"Clinical translation":1,
"Gastrin-radioligand":1,
"Medullary thyroid cancer":5,
"Radionuclide therapy":1,
"Radiopharmaceutical development":1,
"Differentiated cancer thyroid":1,
"Radioactive iodine 131":1,
"Successful ablation":1,
"Thyroglobulin level":1,
"DACH":1,
"EYA":1,
"SIX":1,
"tumor growth":1,
"Imaging":1,
"Neoplasm":1,
"Nuclear":1,
"PET/CT":1,
"clinicopathologic characteristics":1,
"double primary malignancies":1,
"Angiosarcoma":1,
"Epithelioid angiosarcoma":1,
"Therapy":3,
"diagnostic caveats":1,
"fine needle aspiration":3,
"oxyphilic":1,
"parathyroid carcinoma":1,
"Dosimetric predictors":1,
"hypothyroidism":1,
"intensity-modulated radiation therapy":1,
"cytomorphology":1,
"histopathology":1,
"parathyroid hormone":1,
"parathyroid lesion":1,
"expression profile":1,
"function":1,
"miRNA":1,
"benign follicular nodule":1,
"follicular neoplasm":1,
"liquid-based cytology":1,
"Differentiated thyroid cancer":2,
"SEER":1,
"marital status":1,
"survival analysis":1,
"RAS":2,
"RET/PTC":1,
"iodine intake":1,
"Gene fusion":1,
"Gene rearrangement":1,
"Growth":1,
"Microenvironment":1,
"Monoclonal antibodies":1,
"NGF":1,
"Nerves":1,
"Therapeutic target":1,
"TrkA":1,
"p75NTR":1,
"squamous cells in thyroid FNA":1,
"Computed tomography":1,
"Ectopic thyroid":1,
"Goiter":1,
"Incidental thyroid nodule":1,
"Long noncoding RNAs":1,
"Nuclear receptor":1,
"SRA":1,
"Transcriptional coactivator":1,
"Multikinase inhibitor":1,
"PTEN":1,
"Regorafenib":1,
"safety":1,
"side effect management":1,
"tyrosine kinase inhibitor":2,
"head and neck ultrasound":2,
"microcalcifications":1,
"psammoma bodies":1,
"TROP-2":1,
"automated image analysis":1,
"differential diagnosis":1,
"malignant disease":1,
"Angiogenesis":2,
"Invasion":2,
"MicroRNA":2,
"Triple negative breast cancer":2,
"VEGF":1,
"Carney complex":1,
"Medullary carcinoma":1,
"PKA":1,
"Sickle cell disease":1,
"haematological malignancies":1,
"record linkage studies":1,
"image orientation":1,
"shear wave elastography":1,
"thyroid nodule stiffness":1,
"AKT pathway":1,
"CHIP":1,
"MAPK pathway":1,
"G-quadruplex":1,
"RET oncogene":1,
"gene promoter":1,
"naphthalene diimide":1,
"TRβ agonists":1,
"cell differentiation":1,
"local hypothyroidism":1,
"thyroid hormone receptor":1,
"triiodothyronine":1,
"prognostic factors":1,
"thyroid correlative autoantibodies":1,
"thyroid functional parameters":1,
"Lymph nodes":1,
"neck dissection":2,
"risk factors":1,
"FNA":1,
"Fine needle biopsy":1,
"Pediatric papillary carcinoma":1,
"Pediatric thyroid nodule":1,
"PI3K":1,
"β-catenin":1,
"CDX2":1,
"Helicobacter pylori":1,
"cell proliferation":1,
"gastric cardia cancer":1,
"alcohol consumption":1,
"E7080":1,
"Lenvatinib":1,
"RET mutations":1,
"pericyte":1,
"migration":1,
"osteopontin splice variants (OPN-SV)":1,
"osteopontin-a (OPNa)":1,
"Iodine":1,
"Thailand":1,
"Thyroid neoplasms":3,
"cancer of alimentary tract":1,
"periostin":1,
"signaling pathways":1,
"diffuse sclerosing variant of papillary carcinoma":1,
"adenoid cystic carcinoma":1,
"mimicking":1,
"tumor":1,
"glutamine":1,
"metabolism":1,
"pathology":1,
"stroma":2,
"NF-κB pathway":1,
"millepachine":1,
"ovarian cancer":1,
"topoisomerase II inhibitor":1,
"Experience":1,
"Hormonal interruption":1,
"I-131 therapy":1,
"Low iodine diet":1,
"Phenomenology":1,
"FOXO3a":1,
"MAPK/Erk pathway":1,
"PAX3":1,
"PI3K/Akt pathway":1,
"Procalcitonin":1,
"Incidence":2,
"Internet":1,
"Korea":1,
"Mortality":2,
"Newspapers":1,
"Risk":2,
"Television":1,
"Childhood":1,
"Second Neoplasm":1,
"Survivors":1,
"Cancer registry":1,
"China":1,
"Case series":1,
"Familial":1,
"Non-medullary carcinoma":1,
"Thyroid cytology":1,
"nitrate":1,
"nitrite":1,
"Adenocarcinoma":1,
"Epidermal growth factor receptor":1,
"Metastatic breast tumor":1,
"Small cell lung cancer":1,
"Hypocalcemia":1,
"Hypoparathyroidism":2,
"Immunosuppression":1,
"Living-donor parathyroid allotransplantation":1,
"HABP2":1,
"Oncogenes":1,
"Exome sequencing":1,
"Somatic evolution":1,
"E3 ubiquitin ligase":1,
"HIPK2":1,
"Hypoxia":1,
"VHL":1,
"WSB1":1,
"struma ovarii":2,
"Elderly":2,
"Radiotherapy":2,
"Surgery":1,
"Modified radical neck dissection":1,
"Multiple endocrine neoplasia":1,
"Chemo-radiotherapy":1,
"isthmus":1,
"Second primary tumor":1,
"Spindle-cell carcinoma":1,
"Synchronous cancer":1,
"aged above 60 years":1,
"aged below 60 years":1,
"clinicopathological characteristics":1,
"comparative analysis":1,
"differentiated thyroid cancers":1,
"elderly patients":1,
"patients aged above 45 years":1,
"treatment outcomes":1,
"BRAF mutation":1,
"molecular diagnosis":1,
"target therapy":1,
"PFS":1,
"first-line":1,
"mRCC":1,
"pazopanib":1,
"real-life":1,
"Second cancer":1,
"BCPAP":1,
"PCBP1":1,
"Poly r(C) binding protein":1,
"miR-490":1,
"Biopsy":1,
"Endoscopic":1,
"Parapharyngeal space tumour":1,
"Pleomorphic adenoma":1,
"Video-assisted":1,
"HULC":1,
"MMP":1,
"lncRNA":1,
"carbon nanoparticles":1,
"lingual squamous cell carcinoma":1,
"lymph node tracers":1,
"Insular carcinoma":1,
"Iodine ablation therapy":1,
"Pelvic mass":1,
"parathyroid glands":1,
"lymph node dissection":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年8月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
